The Parkinson's Disease Society has announced that this year will make its biggest ever spend on research.
Totalling £3.9 million, the money has been upped following the instigation of nine new studies in October.
These studies cover all aspects of Parkinson's disease research, from genetic and environmental causes to drug treatments and complementary therapies.
One of the studies looks at the respite care needs of people with Parkinson's and their carers and another will examine how Parkinson's can be traced to genetic faults.
"It's great news that the society is making such a big investment in research this year," said Dr Kieran Breen, director of research and development for the society.
"It's a big priority for the society – the £3.9 million being invested is about 28 per cent of the budget."
He added that the Parkinson's Disease Society is the key UK funding provider for research into the cause, prevention, treatment and cure for Parkinson's.
It has invested more than £32 million since 1969.